There Is Clear Momentum For CRISPR Therapeutics AG (NASDAQ: CRSP)

CRISPR Therapeutics AG (CRSP) concluded trading on Thursady at a closing price of $86.19, with 4.28 million shares of worth about $369.15 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 79.82% during that period and on Thursady the price saw a gain of […]

Better Times Ahead For CRISPR Therapeutics AG (NASDAQ: CRSP)?

CRISPR Therapeutics AG (CRSP) concluded trading on Wednesday at a closing price of $79.04, with 4.13 million shares of worth about $326.06 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 63.24% during that period and on Wednesday the price saw a gain of […]

Investors Should Take Note Of CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG (CRSP) concluded trading on 01/11/24 at a closing price of $64.84, with 3.64 million shares of worth about $235.76 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 12.80% during that period and on Thursday the price saw a gain of […]

CRISPR Therapeutics AG (NASDAQ: CRSP) – Not A Clear Buying Opportunity?

Capital Research & Management Co has recently announced that it has increased stake in CRISPR Therapeutics AG (NASDAQ:CRSP) by 0.26%. After grabbing 6.09 million shares, the institutional investor is now in possession of 15789.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.66% having worth around $406.09 million. […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.